PFE
41
-4
IP
37
3
SO
50
4
DOW
39
-3
KSS
56
-2
PVH
28
-2
OMC
64
-2
LYB
20
-3
RHI
37
-2
XEL
43
2
VLO
42
2
TXN
50
-2
HP
38
-3
WYNN
45
-3
GWW
62
-5
EA
47
3
NVDA
59
4
FITB
73
-5
ALL
63
2
M
49
-4
PFE
41
-4
IP
37
3
SO
50
4
DOW
39
-3
KSS
56
-2
PVH
28
-2
OMC
64
-2
LYB
20
-3
RHI
37
-2
XEL
43
2
VLO
42
2
TXN
50
-2
HP
38
-3
WYNN
45
-3
GWW
62
-5
EA
47
3
NVDA
59
4
FITB
73
-5
ALL
63
2
M
49
-4
Financhill
Back

PIMCO Corporate & Income Opportunity Fund Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
43

PTY
PIMCO Corporate & Income Opportunity Fund

Last Price:
$12.79
Seasonality Move:
-0.47%
Buy
61

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
43
PIMCO Corporate & Income Opportunity Fund (PTY) is a Sell

Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $12.88. The Score for PTY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fund's stock price today?

  • The PIMCO Corporate & Income Opportunity Fund share price today is $12.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTY is experiencing selling pressure, which indicates risk of future bearish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.87 Buy
Relative Strength Index (14 RSI): 29.79 Sell
Chaikin Money Flow: -1059987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.9 - 13.22) Sell
Bollinger Bands (100): (13.31 - 14.35) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.24 Buy
Relative Strength Index (14 RSI): 78.97 Buy
Chaikin Money Flow: -246560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.8 - 33.24) Buy
Bollinger Bands (100): (10.76 - 24.28) Buy

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.9 Sell
20-day SMA: 13.08 Sell
50-day SMA: 13.42 Sell
200-day SMA: 13.82 Sell
8-day EMA: 8.17 Buy
20-day EMA: 4.25 Buy
50-day EMA: 1.91 Buy
200-day EMA: 0.51 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34 Buy
20-day SMA: 29.06 Buy
50-day SMA: 22.08 Buy
200-day SMA: 13.64 Buy
8-day EMA: 33.98 Buy
20-day EMA: 29.78 Buy
50-day EMA: 23.99 Buy
200-day EMA: 17.62 Buy

PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

PIMCO Corporate & Income Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):